Members Co., Ltd. (TYO:2130)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	16,265	14,388	11,723	17,444	41,801	32,159
Market Cap Growth	22.73%	22.73%	-32.80%	-58.27%	29.98%	85.14%
Enterprise Value	13,190	12,206	9,365	13,973	37,947	29,308
Last Close Price	1274.00	1127.00	874.91	1233.16	2940.75	2271.29
PE Ratio	46.53	41.13	93.04	17.27	29.77	35.89
Forward PE	-	26.04	80.90	29.64	28.66	31.73
PS Ratio	0.73	0.64	0.57	0.99	2.80	2.66
PB Ratio	2.80	2.48	1.98	2.74	7.09	6.97
P/TBV Ratio	2.86	2.53	2.02	2.79	7.25	7.16
P/FCF Ratio	14.14	12.51	20.90	13.85	25.41	18.09
P/OCF Ratio	13.43	11.88	20.07	12.48	25.29	17.54
EV/Sales Ratio	0.59	0.55	0.46	0.79	2.54	2.42
EV/EBITDA Ratio	12.17	11.26	16.43	7.22	16.93	17.68
EV/EBIT Ratio	26.75	24.75	195.11	9.68	20.23	22.41
EV/FCF Ratio	11.47	10.61	16.69	11.09	23.07	16.48
Debt / Equity Ratio	0.16	0.16	0.12	0.10	0.10	0.09
Debt / EBITDA Ratio	0.87	0.87	1.25	0.34	0.27	0.24
Debt / FCF Ratio	0.82	0.82	1.27	0.53	0.36	0.22
Asset Turnover	1.92	1.92	1.79	1.63	1.57	1.51
Inventory Turnover	476.70	476.70	305.19	214.86	257.77	242.12
Quick Ratio	1.47	1.47	1.50	1.79	1.98	1.85
Current Ratio	1.51	1.51	1.57	1.86	2.04	1.91
Return on Equity (ROE)	5.96%	5.96%	2.05%	16.46%	26.72%	20.36%
Return on Assets (ROA)	2.65%	2.65%	0.26%	8.30%	12.31%	10.18%
Return on Capital (ROIC)	4.60%	4.60%	0.44%	13.33%	20.40%	16.94%
Return on Capital Employed (ROCE)	7.60%	7.60%	0.70%	20.80%	30.20%	26.80%
Earnings Yield	2.15%	2.43%	1.07%	5.79%	3.36%	2.79%
FCF Yield	7.07%	7.99%	4.78%	7.22%	3.94%	5.53%
Dividend Yield	2.54%	2.84%	3.54%	2.43%	0.85%	0.77%
Payout Ratio	113.36%	113.36%	310.32%	32.28%	16.03%	19.98%
Buyback Yield / Dilution	1.95%	1.95%	2.13%	0.07%	-0.87%	-0.18%
Total Shareholder Return	4.54%	4.79%	5.67%	2.50%	-0.02%	0.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.